By Peter Nurse
Investing.com — Stocks in focus in premarket trade on Monday, November 30th. Please refresh for updates.
Moderna (NASDAQ:MRNA) stock soared 9% after the biotech company said it will apply for U.S. and European emergency authorization of its Covid-19 vaccine on Monday based on full results from a late-stage study showing its vaccine was 94.1% effective with no serious safety concerns.
Pfizer (NYSE:PFE) stock rose 1.8% after the Financial Times reported that the U.K. is set to approve the pharma giant’s Covid-19 vaccine within days, with the rollout potentially taking place as early as Dec. 7.
Novavax (NASDAQ:NVAX) stock fell 9.2% after the vaccine maker pushed back the start of a U.S.-based, late-stage trial for its experimental Covid-19 vaccine. It now expects the trial to begin in the coming weeks, having earlier eyed November.
S&P Global (NYSE:SPGI) stock fell 2.5% after the data giant agreed to buy IHS Markit for around $39 billion plus $4.8 billion in debt, creating a big player in the increasingly competitive market in financial information.
HSBC (NYSE:HSBC) ADR fell 2% after the Financial Times reported the banking giant is considering a complete exit from U.S. retail banking, an area where it has always struggled.
Apple (NASDAQ:AAPL) stock rose 0.4% despite the Italian antitrust authority fining the tech giant 10 million euros ($12 million) for “aggressive and misleading” commercial practices regarding its iPhones.
Nikola (NASDAQ:NKLA) stock fell 3.1% amid worries that founder Trevor Milton will sell all or part of his 91.6 million shares, about a quarter of all outstanding shares, which he is able to do today. Coincidentally or not, Nikola shares spiked briefly after the company issued a press release saying that General Motors (NYSE:GM) will no longer buy an equity stake in the company, or help to develop its Badger pickup trucks. Nikola will refund all deposits taken for the Badger.